IFIH1 and dermatomyositis: Patients with anti-MDA5 autoantibodies present a severe disease characterized by rapidly progressive ILD, skin ulcers, arthritis, fever, and a mild or even absent muscle involvement, called “amyopathic dermatomyositis” with either an adult or a juvenile presentation [55, 56].